• Home
  • Samyang Holdings Corporation

Samyang Holdings Corporation

About Samyang Holdings Corporation

Samyang Holdings Corporation is specialized in commercialization of first generics and drug delivery system (DDS)-based modified drugs for cancer tratment and development of small-molecule drugs, new biologic drugs, and cancer virus vaccines. 

Samyang is exporting its oncology products to more than 25 countries, and its cytotoxic manufacturing facility is authorized by authorities ...

Read more Show less
Certifications
  • CE
    CE
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Other
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Other
Pharmaceutical Company (generic finished products)
Contact info
Show contact info Hide contact info

Products from Samyang Holdings Corporation (3)

  • FPFs

    Product FPFs

    • Genexol®PM Inj.(Paclitaxel)   • Genexol® Inj.(Paclitaxel) • Nanoxel®M Inj.(Docetaxel) • Docetaxel Inj.(Docetaxel) • Nexatin® Inj.(Oxaliplatin) • Everose® Tab.(Everolimus) • Pemed®S Inj.(Pemetrexed) • Azalid® Inj.(Azacitidine) • Decilid® Inj.(Decitabine) • Lenalid® Inj.(Lenalid...
  • APIs

    Product APIs

    • Paclitaxel (Package : Up to 500g Per request) • Pemetrexed (Package : Up to 1kg Per request) • Bortezomib (Package : Up to 40g Per request)
  • CDMO

    Product CDMO

    • Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY  • CYTOTOXIC API • EU GMP  • JGMP (Japan) • KGMP (Korea) • PIC/S

Samyang Holdings Corporation Resources (1)